|Dr. Robert Alexander||CEO & Director||761.07k||N/A||1970|
|Dr. Adam L. Tomasi||Pres, COO & Sec.||571.07k||N/A||1970|
|Dr. Henrik Sandvad Rasmussen||Chief Medical Officer||424.54k||N/A||1959|
|Mr. Leo J. Redmond||CFO & Principal Accounting Officer||N/A||N/A||N/A|
|Dr. Ruby Casareno Ph.D.||VP of Technical Operations||N/A||N/A||N/A|
Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.
Allakos Inc.’s ISS Governance QualityScore as of October 4, 2019 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.